stock decline

Law firm files securities fraud lawsuit against BellRing after 52% stock plunge, alleging failure to disclose inventory and supply chain issues.

Ancient Art L.P. sold 700,000 Frontier Group shares worth $3.1M in Q4, reducing its stake while maintaining 3.82% ownership amid airline sector challenges.

Inovio Pharmaceuticals faces class action lawsuit over alleged false statements regarding manufacturing defects and regulatory prospects after FDA rejected accelerated approval, causing 24% stock decline.

Class action filed against BellRing for allegedly misrepresenting sales growth through customer inventory buildup. Stock fell 33% after weaker-than-expected 2025 outlook disclosure.

Law firm investigates Franklin BSP Realty Trust for potential securities violations after missing earnings expectations and reporting significant asset liquidation delays, triggering a 14% stock decline.

Pomerantz files class action lawsuit against Bath & Body Works for alleged securities violations following missed earnings and stock decline in 2025.

IBM shares fell 13% as AI tools threaten its legacy modernization business, which represents 23% of revenue. Investors worry about automation disrupting this critical earnings stream.

American Sports shares dropped 4.42% despite beating Q4 earnings, as weak 2026 guidance disappointed investors seeking stronger growth outlook.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.

Plug Power faces securities fraud lawsuit over alleged false statements about DOE loan program. Stock declined after executive departures and suspended loan activities.

ACV Auctions stock fell 15% despite beating revenue expectations, as larger-than-expected losses and 2026 profit warnings overshadowed growth gains.

NuScale Power stock plummeted 77% amid market concerns about small reactor viability, despite securing regulatory approval for a Romania project expected online in 2033.

Activist investor Dan Loeb's Third Point builds $174.8M Chipotle stake as stock faces valuation pressures from weak 2026 guidance and 28% decline.

Navan faces securities fraud lawsuit over IPO disclosure gaps regarding undisclosed sales expenses and slowing revenue growth. Stock fell 48% since offering.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Corcept Therapeutics faces class action lawsuit for allegedly misleading statements about relacorilant's clinical evidence. FDA rejected the drug application, causing stock to plummet 50%.

Remitly shares fell 5% despite a bullish analyst upgrade, as market concerns about AI and stablecoins weigh on the remittance sector broadly.

Salesforce shares fell 3.86% amid software sector weakness and AI disruption concerns. Stock hits 52-week low as investors await earnings guidance on AI impact.

Surgery Partners shares fell 39.7% as major fund exits position amid high debt concerns, despite 6.6% revenue growth. Elevated leverage weighs on investor confidence.

Law firm Block & Leviton investigates Gemini Space Station stock collapse following three executive departures and 75% price decline from IPO, citing potential securities law violations.